Vaccines
National Institutes of Health announced the initiation of a multi-site, Phase 3 clinical trial evaluating the investigational COVID-19 vaccine candidate AZD1222. The trial aims to enroll approximately 30,000 adult volunteers at 80 sites in the United States to determine if the vaccine can prevent symptomatic coronavirus disease 2019 (COVID-19)
Vaccines
Canada's hopes for having one of the earliest coronavirus vaccines available have been significantly delayed due to China's reluctance to approve the shipment of a candidate vaccine developed by CanSino Biologics, Inc. Dr. Scott Halperin, director of the Canadian Centre for Vaccinology at Dalhousie University in
Vaccines
Taiwan's Food and Drug Administration (FDA) has conditionally approved United Biomedical, Inc., Asia (UBI Asia) to start clinical trials for its coronavirus vaccine, marking the second Taiwanese-made vaccine to enter the human testing phase. This move follows Adimmune Corporation's approval to begin Phase I clinical trials
Vaccines
As COVID-19 vaccines enter critical phase 3 trials, Johnson & Johnson is gearing up for the largest study yet, aiming to enroll 60,000 participants. This massive trial will kick off next month and is set to surpass the enrollment of rival vaccine makers Moderna and Pfizer, who have already
Vaccines
In a significant development towards combating the COVID-19 pandemic, the institutional ethics committees of the Bharati Hospital and Research Centre, KEM Hospital, and other hospitals in Pune have granted approval for the conduct of clinical trials of the Oxford University's AstraZeneca COVID-19 vaccine. The trials, which aim to
Vaccines
As India pushes forward in its fight against COVID-19, the institutional ethics committees of the Bharati Hospital and Research Centre, and KEM Hospital have given a go-ahead for the clinical trials of the Oxford University's AstraZeneca Covid-19 vaccine. The trials are expected to begin soon, with the Bharati
Vaccines
The George Washington University (GW) is participating in a clinical trial for an investigational COVID-19 vaccine, as part of the COVID-19 Prevention Network established by the National Institute of Allergy and Infectious Diseases (NIAID) of the National Institutes of Health (NIH). The university will serve as a trial site for
Vaccines
Chimpanzees, in the form of a cold virus engineered to carry a piece of the COVID-19 virus, are at the forefront of a novel approach to developing a coronavirus vaccine. The AstraZeneca-Oxford University vaccine, dubbed ChAdOx1 nCoV-19 (AZD1222), is set to begin Phase III trials in Palm Beach County, with
Vaccines
Amid India's growing COVID-19 caseload, with over 1.91 million cases recorded, the country has accelerated its vaccine development efforts. Two homegrown vaccines, Covaxin and ZyCoV-D, have been granted permission to start phase II of their experimental vaccine trials. This development comes just three weeks after these vaccines
Vaccines
Moderna, a Cambridge-based biotechnology company, has commenced the Phase 3 clinical trial of its coronavirus vaccine candidate, mRNA-1273, in collaboration with the National Institute of Allergy and Infectious Diseases (NIAID) and the Biomedical Advanced Research and Development Authority (BARDA) of the U.S. Department of Health and Human Services. The
Vaccines
Scientists at the George Washington University (GW) have been selected to participate in a clinical trial for an experimental COVID-19 vaccine, aiming to develop new tools to prevent the disease caused by the novel coronavirus. The trial, sponsored by the National Institute of Allergy and Infectious Diseases (NIAID) of the
Vaccines
Results from a Phase I/II trial published in The Lancet indicate that Oxford University's COVID-19 vaccine, ChAdOx1 nCoV-19, also known as AZD1222, has shown no early safety concerns and induced strong immune responses in both parts of the immune system. The vaccine provoked a T cell response
